Mª José
Sánchez Sanz
Publicaciones (41) Publicaciones de Mª José Sánchez Sanz
2023
-
Expresión de factor V de la coagulación en distintas etapas del desarrollo embrionario en ratón
LXIV Congreso Nacional de la SEHH. XXXVIII Congreso Nacional SETH. 38th World Congress of the International Society of Hematology (ISTH)
-
Therapeutic potential of fetal liver cell transplantation in hemophilia A mice
Haematologica, Vol. 108, Núm. 6, pp. 1544-1554
2022
-
Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM)
Leukemia and Lymphoma, Vol. 63, Núm. 14, pp. 3438-3447
-
The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V
International journal of molecular sciences, Vol. 23, Núm. 15
2018
-
Searching for a Cell-Based Therapeutic Tool for Haemophilia A within the Embryonic/Foetal Liver and the Aorta-Gonads-Mesonephros Region
Thrombosis and Haemostasis, Vol. 118, Núm. 8, pp. 1370-1381
2017
-
A population of hematopoietic stem cells derives from GATA4-expressing progenitors located in the placenta and lateral mesoderm of mice
Haematologica, Vol. 102, Núm. 4, pp. 647-655
-
Characterization of a Fetal Liver Cell Population Endowed with Long-Term Multiorgan Endothelial Reconstitution Potential
Stem Cells, Vol. 35, Núm. 2, pp. 507-521
2013
-
Single site-specific integration targeting coupled with embryonic stem cell differentiation provides a high-throughput alternative to in vivo enhancer analyses
Biology Open, Vol. 2, Núm. 11, pp. 1229-1238
2010
-
Cis-regulatory remodeling of the SCL locus during vertebrate evolution
Molecular and Cellular Biology, Vol. 30, Núm. 24, pp. 5741-5751
-
Enhanced hematovascular contribution of SCL 3′ enhancer expressing fetal liver cells uncovers their potential to integrate in extramedullary adult niches
Stem Cells, Vol. 28, Núm. 1, pp. 100-112
2009
-
Cell fusion contributes to pericyte formation after stroke
Journal of Cerebral Blood Flow and Metabolism, Vol. 29, Núm. 3, pp. 480-485
-
In vivo fate mapping with SCL regulatory elements identifies progenitors for primitive and definitive hematopoiesis in mice
Mechanisms of Development, Vol. 126, Núm. 10, pp. 863-872
2008
-
A novel mode of enhancer evolution: The Tal1 stem cell enhancer recruited a MIR element to specifically boost its activity
Genome Research, Vol. 18, Núm. 9, pp. 1422-1432
-
Organ-injury-induced reactivation of hemangioblastic precursor cells
Leukemia, Vol. 22, Núm. 1, pp. 103-113
2007
-
The notch pathway positively regulates programmed cell death during erythroid differentiation
Leukemia, Vol. 21, Núm. 7, pp. 1496-1503
2006
-
The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression
Developmental Dynamics, Vol. 235, Núm. 11, pp. 3144-3155
2005
-
Transgenic analysis of the stem cell leukemia +19 stem cell enhancer in adult and embryonic hematopoietic and endothelial cells
Stem Cells, Vol. 23, Núm. 9, pp. 1378-1388
2004
-
Kidney, blood, and endothelium: Developmental expression of stem cell leukemia during nephrogenesis
Kidney International, Vol. 65, Núm. 4, pp. 1162-1169
-
The scl +18/19 Stem Cell Enhancer Is Not Required for Hematopoiesis: Identification of a 5′ Bifunctional Hematopoietic-Endothelial Enhancer Bound by Fli-1 and Elf-1
Molecular and Cellular Biology, Vol. 24, Núm. 5, pp. 1870-1883
2003
-
Manipulation of Mouse Hematopoietic Progenitors by Specific Retroviral Infection
Journal of Biological Chemistry, Vol. 278, Núm. 44, pp. 43556-43563